nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinolazepam—GABRR1—Ion channel transport—RYR2—dilated cardiomyopathy	0.0177	0.0177	CbGpPWpGaD
Cinolazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0172	0.0172	CbGpPWpGaD
Cinolazepam—GABRR1—Ion channel transport—PLN—dilated cardiomyopathy	0.0172	0.0172	CbGpPWpGaD
Cinolazepam—GABRR2—Ion channel transport—RYR2—dilated cardiomyopathy	0.0168	0.0168	CbGpPWpGaD
Cinolazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0164	0.0164	CbGpPWpGaD
Cinolazepam—GABRR2—Ion channel transport—PLN—dilated cardiomyopathy	0.0164	0.0164	CbGpPWpGaD
Cinolazepam—GABRG3—Ion channel transport—RYR2—dilated cardiomyopathy	0.0139	0.0139	CbGpPWpGaD
Cinolazepam—GABRB1—Ion channel transport—RYR2—dilated cardiomyopathy	0.0137	0.0137	CbGpPWpGaD
Cinolazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0135	0.0135	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0135	0.0135	CbGpPWpGaD
Cinolazepam—GABRG3—Ion channel transport—PLN—dilated cardiomyopathy	0.0135	0.0135	CbGpPWpGaD
Cinolazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0133	0.0133	CbGpPWpGaD
Cinolazepam—GABRB1—Ion channel transport—PLN—dilated cardiomyopathy	0.0133	0.0133	CbGpPWpGaD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.0129	0.0129	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.0123	0.0123	CbGpPWpGaD
Cinolazepam—GABRB2—Ion channel transport—RYR2—dilated cardiomyopathy	0.0117	0.0117	CbGpPWpGaD
Cinolazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0114	0.0114	CbGpPWpGaD
Cinolazepam—GABRB2—Ion channel transport—PLN—dilated cardiomyopathy	0.0114	0.0114	CbGpPWpGaD
Cinolazepam—GABRA5—Ion channel transport—RYR2—dilated cardiomyopathy	0.0113	0.0113	CbGpPWpGaD
Cinolazepam—GABRA3—Ion channel transport—RYR2—dilated cardiomyopathy	0.0111	0.0111	CbGpPWpGaD
Cinolazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.011	0.011	CbGpPWpGaD
Cinolazepam—GABRA5—Ion channel transport—PLN—dilated cardiomyopathy	0.011	0.011	CbGpPWpGaD
Cinolazepam—GABRA2—Ion channel transport—RYR2—dilated cardiomyopathy	0.0109	0.0109	CbGpPWpGaD
Cinolazepam—GABRB3—Ion channel transport—RYR2—dilated cardiomyopathy	0.0109	0.0109	CbGpPWpGaD
Cinolazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0108	0.0108	CbGpPWpGaD
Cinolazepam—GABRA3—Ion channel transport—PLN—dilated cardiomyopathy	0.0108	0.0108	CbGpPWpGaD
Cinolazepam—GABRG2—Ion channel transport—RYR2—dilated cardiomyopathy	0.0107	0.0107	CbGpPWpGaD
Cinolazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0107	0.0107	CbGpPWpGaD
Cinolazepam—GABRA2—Ion channel transport—PLN—dilated cardiomyopathy	0.0106	0.0106	CbGpPWpGaD
Cinolazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0106	0.0106	CbGpPWpGaD
Cinolazepam—GABRB3—Ion channel transport—PLN—dilated cardiomyopathy	0.0106	0.0106	CbGpPWpGaD
Cinolazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0104	0.0104	CbGpPWpGaD
Cinolazepam—GABRG2—Ion channel transport—PLN—dilated cardiomyopathy	0.0104	0.0104	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—ABCC9—dilated cardiomyopathy	0.0103	0.0103	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.0102	0.0102	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.01	0.01	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00991	0.00991	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00986	0.00986	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00962	0.00962	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00945	0.00945	CbGpPWpGaD
Cinolazepam—GABRA1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00933	0.00933	CbGpPWpGaD
Cinolazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00909	0.00909	CbGpPWpGaD
Cinolazepam—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	0.00908	0.00908	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00855	0.00855	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00831	0.00831	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00816	0.00816	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00812	0.00812	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00802	0.00802	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—ABCC9—dilated cardiomyopathy	0.008	0.008	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00796	0.00796	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00782	0.00782	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00778	0.00778	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00767	0.00767	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00684	0.00684	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00683	0.00683	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—ABCC9—dilated cardiomyopathy	0.00664	0.00664	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00655	0.00655	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00652	0.00652	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00641	0.00641	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—ACTN2—dilated cardiomyopathy	0.00636	0.00636	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00636	0.00636	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00625	0.00625	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00625	0.00625	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00614	0.00614	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00614	0.00614	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—ACTN2—dilated cardiomyopathy	0.0061	0.0061	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00599	0.00599	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00598	0.00598	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00598	0.00598	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00586	0.00586	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.0057	0.0057	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.0057	0.0057	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00556	0.00556	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00546	0.00546	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.0053	0.0053	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00524	0.00524	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00483	0.00483	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00475	0.00475	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00469	0.00469	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00469	0.00469	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00462	0.00462	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00462	0.00462	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00436	0.00436	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.0043	0.0043	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00406	0.00406	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00395	0.00395	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00395	0.00395	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00395	0.00395	CbGpPWpGaD
Cinolazepam—GABRB3—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00393	0.00393	CbGpPWpGaD
Cinolazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00391	0.00391	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00388	0.00388	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00384	0.00384	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00384	0.00384	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00381	0.00381	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00378	0.00378	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00377	0.00377	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00377	0.00377	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00375	0.00375	CbGpPWpGaD
Cinolazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00373	0.00373	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00372	0.00372	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.0037	0.0037	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.0037	0.0037	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00368	0.00368	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00368	0.00368	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00367	0.00367	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00361	0.00361	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00361	0.00361	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00357	0.00357	CbGpPWpGaD
Cinolazepam—GABRB3—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.00355	0.00355	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.0035	0.0035	CbGpPWpGaD
Cinolazepam—GABRR1—Ion channel transport—RAF1—dilated cardiomyopathy	0.00348	0.00348	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00344	0.00344	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00342	0.00342	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00336	0.00336	CbGpPWpGaD
Cinolazepam—GABRR2—Ion channel transport—RAF1—dilated cardiomyopathy	0.00332	0.00332	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00326	0.00326	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00325	0.00325	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00316	0.00316	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00316	0.00316	CbGpPWpGaD
Cinolazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00307	0.00307	CbGpPWpGaD
Cinolazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00303	0.00303	CbGpPWpGaD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00294	0.00294	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00294	0.00294	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00281	0.00281	CbGpPWpGaD
Cinolazepam—GABRG3—Ion channel transport—RAF1—dilated cardiomyopathy	0.00274	0.00274	CbGpPWpGaD
Cinolazepam—GABRB1—Ion channel transport—RAF1—dilated cardiomyopathy	0.00269	0.00269	CbGpPWpGaD
Cinolazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00259	0.00259	CbGpPWpGaD
Cinolazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00251	0.00251	CbGpPWpGaD
Cinolazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00247	0.00247	CbGpPWpGaD
Cinolazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00243	0.00243	CbGpPWpGaD
Cinolazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00241	0.00241	CbGpPWpGaD
Cinolazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00237	0.00237	CbGpPWpGaD
Cinolazepam—GABRB3—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.00236	0.00236	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00231	0.00231	CbGpPWpGaD
Cinolazepam—GABRB2—Ion channel transport—RAF1—dilated cardiomyopathy	0.0023	0.0023	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00228	0.00228	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—RAF1—dilated cardiomyopathy	0.00225	0.00225	CbGpPWpGaD
Cinolazepam—GABRA5—Ion channel transport—RAF1—dilated cardiomyopathy	0.00224	0.00224	CbGpPWpGaD
Cinolazepam—GABRA3—Ion channel transport—RAF1—dilated cardiomyopathy	0.0022	0.0022	CbGpPWpGaD
Cinolazepam—GABRA2—Ion channel transport—RAF1—dilated cardiomyopathy	0.00216	0.00216	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—RAF1—dilated cardiomyopathy	0.00215	0.00215	CbGpPWpGaD
Cinolazepam—GABRB3—Ion channel transport—RAF1—dilated cardiomyopathy	0.00214	0.00214	CbGpPWpGaD
Cinolazepam—GABRG2—Ion channel transport—RAF1—dilated cardiomyopathy	0.00211	0.00211	CbGpPWpGaD
Cinolazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00207	0.00207	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00195	0.00195	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00189	0.00189	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00186	0.00186	CbGpPWpGaD
Cinolazepam—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	0.00184	0.00184	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00182	0.00182	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00181	0.00181	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00178	0.00178	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—RAF1—dilated cardiomyopathy	0.00177	0.00177	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—RAF1—dilated cardiomyopathy	0.00174	0.00174	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00156	0.00156	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—RAF1—dilated cardiomyopathy	0.00149	0.00149	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—RAF1—dilated cardiomyopathy	0.00145	0.00145	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—RAF1—dilated cardiomyopathy	0.00142	0.00142	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—RAF1—dilated cardiomyopathy	0.0014	0.0014	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—RAF1—dilated cardiomyopathy	0.00139	0.00139	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—RAF1—dilated cardiomyopathy	0.00136	0.00136	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00124	0.00124	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00121	0.00121	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	0.00119	0.00119	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00116	0.00116	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000952	0.000952	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000938	0.000938	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000801	0.000801	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000779	0.000779	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000764	0.000764	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000751	0.000751	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000746	0.000746	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000733	0.000733	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000641	0.000641	CbGpPWpGaD
